The status of hepatitis B control in the African region

Lucy Breakwell, Carol Tevi-Benissan, Lana Childs, Richard Mihigo, Rania Tohme, Lucy Breakwell, Carol Tevi-Benissan, Lana Childs, Richard Mihigo, Rania Tohme

Abstract

The World Health Organization (WHO) African Region has approximately 100 million people with chronic hepatitis B virus (HBV) infection. This review describes the status of hepatitis B control in the Region. We present hepatitis B vaccine (HepB) coverage data and from available data in the published literature, the impact of HepB vaccination on hepatitis B surface antigen (HBsAg) prevalence, a marker of chronic infection, among children, HBsAg prevalence in pregnant women, and risk of perinatal transmission. Lastly, we describe challenges with HepB birth dose (HepB-BD) introduction reported in the Region, and propose strategies to increase coverage. In 2015, regional three dose HepB coverage was 76%, and 16(34%) of 47 countries reported ≥ 90% coverage. Overall, 11 countries introduced HepB-BD; only nine provide universal HepB-BD, and of these, five reported ≥ 80% coverage. From non-nationally representative serosurveys among children, HBsAg prevalence was lower among children born after HepB introduction compared to those born before HepB introduction. However, some studies still found HBsAg prevalence to be above 2%. From limited surveys among pregnant women, the median HBsAg prevalence varied by country, ranging from 1.9% (Madagascar) to 16.1% (Niger); hepatitis B e antigen (HBeAg) prevalence among HBsAg-positive women ranged from 3.3% (Zimbabwe) to 28.5% (Nigeria). Studies in three countries indicated that the risk of perinatal HBV transmission was associated with HBeAg expression or high HBV DNA viral load. Major challenges for timely HepB-BD administration were poor knowledge of or lack of national HepB-BD vaccination guidelines, high prevalence of home births, and unreliable vaccine supply. Overall, substantial progress has been made in the region. However, countries need to improve HepB3 coverage and some countries might need to consider introducing the HepB-BD to help achieve the regional hepatitis B control goal of < 2% HBsAg prevalence among children < 5 years old by 2020. To facilitate HepB-BD introduction and improve timely coverage, strategies are needed to reach both facility-based and home births. Strong political commitment, clear policy recommendations and staff training on HepB-BD administration are also required. Furthermore, high quality nationally representative serosurveys among children are needed to inform decision makers about progress towards the regional control goal.

Keywords: Hepatitis B control; hepatitis B prevalence; vaccination.

Figures

Figure 1
Figure 1
Childhood hepatitis B vaccination coverage in the World Health Organization African Region compared with global coverage, 1985-2015

References

    1. World Health Organization Hepatitis B vaccines. Weekly Epidemiological Record. 2009;84(40):405–20.
    1. World Health Organization . Regional Office for Africa, editor. 2016. Hepatitis Fact Sheet.
    1. World Health Organization . Sixty-fourth session of the WHO Regional Committee for Africa. (cited 17 february 2017)
    1. World Health Organization . WHO-UNICEF estimates of HepB3 coverage. 2016. (updated 03/03/2017; cited 2017 04/3/2017)
    1. World Health Organization . WHO-UNICEF estimates of HepB_BD coverage. 2016. (updated 03/03/2017; cited 2017 04/03/2017)
    1. World Health Organization . WHO Vaccine-Preventable Diseases: Monitoring System. 2016 Global Summary. 2016. (updated 12/1/2016; cited 2016 10/3/2016)
    1. UNICEF . UNICEF Data: Monitoring the Situation of Children and Women. 2016. (updated 02/1/2016; cited 2016 10/3/2016)
    1. UNAIDS . HIV estimates with uncertainty bounds 1990-2015. 2016. (November 14, 2016)
    1. Kourtis AP, Bulterys M, Hu DJ, Jamieson DJ. HIV-HBV coinfection-a global challenge. N Engl J Med. 2012 May 10;366(19):1749–52.
    1. World Health Organization . A review. Global compliance with Hepatitis B vaccine birth dose and factors related to timely schedule. (cited 2016 November 14, 2016)
    1. World Health Organization . Hepatitis B (HepB3) immunization coverage estimates by WHO region. 2016. (accessed 12/14/2016)
    1. WHO/UNICEF . Coverage estimates for 1980-2015: Regional Global Coverage. 2016. (cited 04/03/2017)
    1. Chotard J, Inskip HM, Hall AJ, Loik F, Mendy M, Whittle H, et al. The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B. J Infect Dis. 1992 Oct;166(4):764–8.
    1. Vall Mayans M, Hall AJ, Inskip HM, Chotard J, Lindsay SW, Coromina E, et al. Risk factors for transmission of hepatitis B virus to Gambian children. Lancet. 1990 Nov 3;336(8723):1107–9.
    1. Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, et al. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. The Lancet. 1993 May 1;341(8853):1129–31.
    1. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine. 1999 Aug 6;17(23-24):2946–50.
    1. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, et al. Observational study on vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ. 2002 Sep 14;325(7364):569.
    1. van der Sande MAB, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, et al. Long-Term Protection against Carriage of Hepatitis B Virus after Infant Vaccination. The Journal of Infectious Diseases. 2006 Jun 1;193(11):1528–35. Epub 2006 Apr 25.
    1. Peto TJ, Mendy ME, Lowe Y, Webb EL, Whittle HC, Hall AJ. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program. BMC Infectious Diseases. 2014;14(7):1471–2334.
    1. Akenami FOT, Koskiniemi M, Ekanem EE, Bolarin DM, Vaheri A. Seroprevalence and coprevalence of HIV and HBsAg in Nigerian children with/without protein energy malnutrition. Acta Tropica. 1997;(64):167–74.
    1. Odusanya OO, Alufohai FE, Meurice FP, Wellens R, Weil J, Ahonkhai VI. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria. International Journal of Infectious Diseases. 2005 May;9(3):139–43.
    1. Odusanya OO, Alufohai E, Meurice FP, Ahonkhai VI. Five-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria. Human Vaccines. 2011;7(6):625–9.
    1. Sadoh AE, Ofili A. Hepatitis B infection among Nigerian children admitted to a children's emergency room. African Health Sciences. 2014 Jun;14(2):377–83.
    1. Okonko I, Okerentugba P, Innocient-Adiele H. Detection of Hepatitis B Surface Antigen (HBsAg) among Children in Ibadan, Southwestern Nigeria. The Internet Journal of Tropical Medicine. 2012;10(1)
    1. Rapicetta M, Stroffolini T, Ngatchu T, Chionne P, Ciccaglione AR, Lantum D, et al. Age- and sex-related study of HBV-DNA in HBsAg asymptomatic children from an endemic area (Cameroon) Annals of Tropical Paediatrics. 1991
    1. Rey-Cuille MA, Njouom R, Bekondi C, Seck A, Gody C, Bata P, et al. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic, and Senegal after the integration of HBV vaccine in the Expanded Program on Immunization. The Pediatric Infectious Disease Journal. 2013 Oct;32(10):1110–5.
    1. Martinson FE, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol. 1998 Mar 1;147(5):478–87.
    1. Dassah S, Sakyi SA, Frempong MT, Luuse AT, Ephraim RK, Anto EO, et al. Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study. PLoS One. 2015;10(12):e0145209.
    1. Ampah KA, Pinho-Nascimento CA, Kerber S, Asare P, De-Graft D, Adu-Nti F, et al. Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in Ghana. PLoS One. 2016;11(6):e0156864.
    1. Excler JL, Yvonnet B, Gaye Y, Monnereau A, Mangin JL, Schlumberger M, et al. Inclusion de la vaccination contre l'hépatite B dans le Programme élargi de vaccination: étude de faisabilité dans la région médicale de Kolda (Sénégal) Cahiers Santé. 1995;5:37–42.
    1. Sall Diallo A, Sarr M, Fall Y, Diagne C, Kane MO. Hepatitis B infection in infantile population in Senegal. Dakar Medical. 2004;49(2):136–42.
    1. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, Sim J. Preimmunization epidemiology of hepatitis B virus infection in South African children. Journal of Medical Virology. 1999 Jun;58(2):111–5.
    1. Schoub BD, Matai U, Singh B, Blackburn NK, Levin JB. Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa. Bulletin of the World Health Organization. 2002;80(4):277–81.
    1. Amponsah-Dacosta E, Lebelo RL, Rakgole JN, Burnett RJ, Selabe SG, Mphahlele MJ. Evidence for a change in the epidemiology of hepatitis b virus infection after nearly two decades of universal hepatitis B vaccination in South Africa. Journal of Medical Virology. 2014 Jun;86(6):918–24.
    1. Pellizzer G, Ble C, Zamperetti N, Stroffolini T, Upunda G, Rapicetta M, et al. Serological survey of hepatitis B infection in Tanzania. Public Health. 1994 Nov;108(6):427–31.
    1. Muro FJ, Fiorillo SP, Sakasaka P, Odhiambo C, Reddy EA, Cunningham CK, et al. Seroprevalence of Hepatitis B and C Viruses Among Children in Kilimanjaro Region, Tanzania. J Pediatric Infect Dis Soc. 2013 Dec;2(4):320–6.
    1. De Paschale M, Ceriani C, Cerulli T, Cagnin D, Cavallari S, Ndayake J, Zaongo D, Priuli G, Vigano P, Clerici P. Prevalence of HBV, HDV, HCV and HIV Infection During Pregnancy in Northern Benin. Journal of Medical Virology. 2014;86:1281–7. Epub 29 April 2014.
    1. Sangare L, Sombie R, Combassere AW, Kouanda A, Kania D, Zerbo O, et al. Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso. Bull Soc Pathol Exot. 2009 Oct;102(4):226–9.
    1. Nacro B, Dao B, Dahourou H, Hien F, Charpentier-Gautier L, Meda N, et al. HBs antigen carrier state in pregnant women in Bobo Dioulasso (Burkina Faso) Dakar Med. 2000;45(2):188–90.
    1. Collenberg E, Ouedraogo T, Ganame J, Fickenscher H, Kynast-Wolf G, Becher H, et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol. 2006 May;78(5):683–92.
    1. Ilboudo D, Karou D, Nadembega WMC, Savadogo A, Djeneba O, Pignatelli S, Pietra V, Bere A, Simpore J, Traore AS. Prevalence of Human Herpes Virus-8 and Hepatitis B Virus among HIV Seropositive Pregnant Women Enrolled in the Mother-to-child HIV Transmission Prevention Program at Saint Camille Medical Centre in Burkina Faso. Pakistan Journal of Biological Sciences. 2007;10(17):2831–7.
    1. Ouermi D, Simpore J, Belem AM, Sanou DS, Karou DS, Ilboudo D, et al. Co-infection of Toxoplasma gondii with HBV in HIV-infected and uninfected pregnant women in Burkina Faso. Pak J Biol Sci. 2009 Sep 1;12(17):1188–93.
    1. Simpore J, Granato M, Santarelli R, Nsme RA, Coluzzi M, Pietra V, et al. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol. 2004 Sep;31(1):78–80.
    1. Simpore J, Savadogo A, Ilboudo D, Nadambega MC, Esposito M, Yara J, et al. Toxoplasma gondii, HCV and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol. 2006 Jun;78(6):730–3.
    1. Ekra D, Herbinger KH, Konate S, Leblond A, Fretz C, Cilote V, et al. A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire. Vaccine. 2008 May 23;26(22):2753–61.
    1. Lohoues-Kouacou MJ, Toure M, Hillah J, Camara BM, N'Dri N, Kouame KJ, et al. Materno-fetal transmission of hepatitis B virus in Ivory Coast - Plea for mass vaccination. Sante. 1998 Nov-Dec;8(6):401–4.
    1. Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, et al. HBV and HCV Prevalence and Viraemia in HIV-Positive and HIV-Negative Pregnant Women in Abidjan, Cote d'Ivoire: The ANRS 1236 Study. Journal of Medical Virology. 2004 Sep;74(1):34–40.
    1. Apea-Kubi KA, Yamaguchi S, Sakyi B, Ofori-Adjei D. HTLV-1 and other viral sexually transmitted infections in antenatal and gynaecological patients in Ghana. West African Journal Medicine. 2006;25(1)
    1. Candotti D, Danso K, Allain JP. Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. Journal of General Virology. 2007 Oct;88(Pt 10):2686–95.
    1. Cho Y, Bonsu G, Akoto-Ampaw A, Nkrumah-Mills G, Nimo JA, Park JK, et al. The prevalence and risk factors for hepatitis B Surface Ag Positivity in Pregnant Women in Eastern Region of Ghana. Gut and Liver. 2012;6(2):235–40.
    1. Ephraim R, Donko I, Sakyi SA, Ampong J, Agbodjakey H. Seroprevalence and risk factors of Hepatitis B and Hepatitis C infections among pregnant women in the Asante Akim North Municipality of the Ashanti region, Ghana; a cross sectional study. Afr Health Sci. 2015 Sep;15(3):709–13.
    1. Sidibe S, Sacko BY, Traore I. Prevalence of serologic markers of the hepatitis B virus in pregnant women of Bamako, Mali. Bull Soc Pathol Exot. 2001 Nov;94(4):339–41.
    1. MacLean B, Hess RF, Bonvillain E, Kamate J, Dao D, Cosimano A, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. S Afr Med J. 2011 Dec 14;102(1):47–9.
    1. Mansour W, Malick FZ, Sidiya A, Ishagh E, Chekaraou MA, Veillon P, et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol. 2012 Aug;84(8):1186–98.
    1. Mamadou S, Ide M, Maazou AR, Aoula B, Labo S, Bozari M. HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa. HIV AIDS (Auckl). 2012;4:1–4. Epub 2012 Jan 21.
    1. Buseri FI, Seiyaboh E, Jeremiah ZA. Surveying Infections among Pregnant Women in the Niger Delta Nigeria. J Glob Infect Dis. 2010;2(3):203–11.
    1. Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virol J. 2011 Jan 12;8:12.
    1. Eze M, Buseri FI, Wachukwu CK, Nnatuanya IN. Effects of Hepatitis B Infection on Haemtological Parameters in Pregnancy in Port Harcourt, Nigeria. Research Journal of Medical Sciences. 2009;3(6):194–7.
    1. Ikeako L, Ezegwui H, Ajah L, Dim C, Okeke T. Seroprevalence of Human Immunodeficiency Virus, Hepatitis B, Hepatitis C, Syphilis, and Co-infections among Antenatal Women in a Tertiary Institution in South East, Nigeria. Ann Med Health Sci Res. 2014 Nov;4(6):954–8.
    1. Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh AI. Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol J. 2012 Dec 27;9:317.
    1. Mbaawuaga EM, Enenebeaku MNO, Okopi JA, Damen JG. Hepatitis B Virus (HBV) Infection among Pregnant Women in Makurdi, Nigeria. African Journal of Biomedical Research. 2008;11:155–9.
    1. Olokoba AB, Salawu FK, Danburam A, Olokoba LB, Midala JK, Badung LH, et al. Hepatitis B virus infection amongst pregnant women in North-eastern Nigeria - a call for action. Niger J Clin Pract. 2011 Jan-Mar;14(1):10–3.
    1. Omalu ICJ, Jibrin A, Olayemi IK, Hassan SC, Mgbemena C, Mgbemena A, et al. Seroprevalence of Malaria and Hepatitis B (HBsAg) with Associated Risk Factors among Pregnant Women Attending Antenatal Clinic in General Hospital Minna, North-Central Nigeria. Annual Review & Research in Biology. 2012;2(4):83–8.
    1. Onakewhor JU, Offor E, Okonofua FE. Maternal and neonatal seroprevalence of hepatitis B surface antigen (HBsAg) in Benin City, Nigeria. J Obstet Gynaecol. 2001 Nov;21(6):583–6.
    1. Osazuwa F, Obinna OV, Chika AF. Sero-epidemiology of Human Immunodeficiency Virus, Hepatitis B and C among Pregnant Women in Rural Communities of Abaji Area Council, Nigeria. TAF Preventive Medicine Bulletin. 2012;11(4)
    1. Pennap GR, Muazu IF, Fatima M. Parallel and Overlapping Hepatitis B and C Virus Infection among Pregnant Women Attending Antenatal in a Rural Clinic in Northern Nigeria. International Journal of Current Microbiology and Applied Sciences. 2015;4(5):16–23.
    1. Pennap GR, Osanga ET, Ubam A. Seroprevalence of Hepatitis B Surface Antigen among Pregnant Women Attending Antenatal Clinic in Federal Medical Center Keffi, Nigeria. Research Journal of Medical Sciences. 2011;5(2):80–2.
    1. Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. The prevalence of hepatitis B and C viral infections among pregnant women. N Am J Med Sci. 2011 May;3(5):238–41.
    1. Usanga V, Abia-Bassey L, Inyang-etoh P, Udoh S, Ani F, Archibong E. Prevalence of Sexually Transmitted Diseases in Pregnant and Non-Pregnant Women in Calabar, Cross River State, Nigeria. The Internet Journal of Gynecology and Obstetrics. 2009;14(2)
    1. Aba HO, Aminu M. Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women. Ann Afr Med. 2016 Jan-Mar;15(1):20–7.
    1. Adegbesan-Omilabu MA, Okunade KS, Gbadegesin A, Olowoselu OF, Oluwole AA, Omilabu SA. Seroprevalence of hepatitis B virus infection among pregnant women at the antenatal booking clinic of a Tertiary Hospital in Lagos Nigeria. Nigerian Journal of Clinical Practice. 2015;18(6)
    1. Anaedobe CG, Fowotade A, Omoruyi CE, Bakare RA. Prevalence, sociodemographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria. Pan Afr Med J. 2015;20:406.
    1. Faleye TO, Adewumi MO, Ifeorah IM, Omoruyi EC, Bakarey SA, Akere A, et al. Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria. Springerplus. 2015;4:43.
    1. Iklaki CU, Emechebe CI, Ago BU, Njoku CO. Sero-prevalence of Hepatitis B infection and its risk factors among women admitted for delivery in Ucth, Calabar, Nigeria. British Journal of Medicine & Medical Research. 2015;8(4):324–33.
    1. Olaleye OA, Kuti O, Makinde NO, Ujah AO, Olaleye OA, Badejoko OO, et al. Perinatal transmission of hepatitis B virus infection in Ile-Ife, South Western, Nigeria. J Neonatal Perinatal Med. 2013;6(3):231–6.
    1. 76Opaleye OO, Igboama MC, Ojo JA, Odewale G. Seroprevalence of HIV, HBV, HCV and HTLV among pregnant women in Southwestern Nigeria. Journal of Immunoassay and Immunochemistry. 2016;37(1):29–42.
    1. Utoo BT Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria. Afr Health Sci. 2013 Dec;13(4):1139–43.
    1. Adeyemi AB, Enabor OO, Ugwu IA, Abraham OA, Bello FA, Olayemi O. Prevalence of antenatal hepatitis B infection in tertiary and non-tertiary health facilities in Ibadan, Nigeria. Niger J Med. 2014 Jul-Sep;23(3):248–53.
    1. Akani CI, Ojule AC, Opurum HC, Ejilemele AA. Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J. 2005 Dec;12(4):266–70.
    1. Baba MM, Onwuka IS, Baba SS. Hepatitis B and C virus infections among pregnant women in Maiduguri, Nigeria. Central European Journal of Public Health. 1999;7(2):60–2.
    1. Onwere S, Chigbu B, Aluka C, Kamanu CI, Okoro O, Ndukwe PE, et al. Risk Factors for Hepatitis B Virus Infection during Pregnancy in South Eastern Nigeria. East Afr Med J. 2012 Mar;89(3):89–93.
    1. Wurie IM, Wurie AT, Gevao SM. Sero-prevalence of hepatitis B virus among middle to high socio-economic antenatal population in Sierra Leone. West Afr J Med. 2005 Jan-Mar;24(1):18–20.
    1. Abongwa LM, Clara AM, Edouard NA, Ngum NH. Sero-Prevalence of Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) Co-Infection among Pregnant Women Residing in Bamenda Health District, Cameroon. International Journal of Current Microbiology and Applied Sciences. 2015;4(12):473–83.
    1. Dionne-Odom J, Mbah R, Rembert NJ, Tancho S, Halle-Ekane GE, Enah C, et al. Hepatitis B, HIV, and Syphilis Seroprevalence in Pregnant Women and Blood Donors in Cameroon. Infect Dis Obstet Gynecol. 2016;2016:4359401.
    1. Ducancelle A, Abgueguen P, Birguel J, Mansour W, Pivert A, Le Guillou-Guillemette H, et al. High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon. PLoS One. 2013;8(11):e80346.
    1. Fomulu NJ, Morfaw FL, Torimiro JN, Nana P, Koh MV, William T. Prevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon? BMC Pregnancy Childbirth. 2013 Aug 08;13:158.
    1. Frambo AA, Atashili J, Fon PN, Ndumbe PM. Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study. BMC Res Notes. 2014 Jun 25;7:394.
    1. Kfutwah AKW, Tejiokem MC, Njouom R. A low proportion of HBeAg among HBsAg- positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon. Virology Journal. 2012;9(62)
    1. Noubiap JJ, Nansseu JR, Ndoula ST, Bigna JJ, Jingi AM, Fokom-Domgue J. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the Far North Region of Cameroon. BMC Public Health. 2015 May 02;15:454.
    1. Makuwa M, Caron M, Souquiere S, Malonga-Mouelet G, Mahe A, Kazanji M. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J Clin Microbiol. 2008 Feb;46(2):754–6.
    1. Awole M, Gebre-Selassie S. Seroprevalence of HBsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia. Ethiop J Health Dev. 2005;19(1)
    1. Desalegn Z, Wassie L, Beyene HB, Mihret A, Ebstie YA. Hepatitis B and human immunodeficiency virus co-infection among pregnant women in resource-limited high endemic setting, Addis Ababa, Ethiopia: implications for prevention and control measures. Eur J Med Res. 2016 Apr 14;21:16.
    1. Metaferia Y, Dessie W, Ali I, Amsalu A. Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study. Epidemiol Health. 2016;38:e2016027.
    1. Molla S, Munshea A, Nibret E. Seroprevalence of hepatitis B surface antigen and anti HCV antibody and its associated risk factors among pregnant women attending maternity ward of Felege Hiwot Referral Hospital, northwest Ethiopia: a cross-sectional study. Virol J. 2015 Dec 02;12:204.
    1. Ramos JM, Toro C, Reyes F, Amor A, Gutierrez F. Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia. Journal of Clinical Virology. 2011 May;51(1):83–5.
    1. Tegegne D, Desta K, Tegbaru B, Tilahun T. Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa, Ethiopia: a cross sectional study. BMC Res Notes. 2014 Apr 15;7:239.
    1. Yohanes T, Zerdo Z, Chufamo N. Seroprevalence and Predictors of Hepatitis B Virus Infection among Pregnant Women Attending Routine Antenatal Care in Arba Minch Hospital, South Ethiopia. Hepat Res Treat. 2016;2016:9290163.
    1. Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014 Mar 01;14:118.
    1. Tiruneh M. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia. Ethiop Med J. 2008;46(4):359–66.
    1. Okoth F, Mbuthia J, Gatheru Z, Murila F, Kanyingi F, Mugo F, et al. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J. 2006 Sep;83(9):485–93.
    1. Randriamahazo TR, Raherinaivo AA, Rakotoarivelo ZH, Contamin B, Rakoto Alson OA, Andrianapanalinarivo HR, et al. Prevalence of hepatitis B virus serologic markers in pregnant patients in Antananarivo, Madagascar. Med Mal Infect. 2015 Jan-Feb;45(1-2):17–20.
    1. Andersson MI, Maponga TG, Ijaz S, Barnes J, Theron GB, Meredith SA, et al. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa. Vaccine. 2013 Nov 12;31(47):5579–84.
    1. Burnett RJ, Ngobeni JM, Francois G, Hoosen AA, Leroux-Roels G, Meheus A, et al. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD AIDS. 2007 Mar;18(3):152–6.
    1. Diale Q, Pattinson R, Chokoe R, Masenyetse L, Mayaphi S. Antenatal screening for hepatitis B virus in HIV-infected and uninfected pregnant women in the Tshwane district of South Africa. S Afr Med J. 2015 Dec 16;106(1):97–100.
    1. Thumbiran NV, Moodley D, Parboosing R, Moodley P. Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting. S Afr Med J. 2014 Apr;104(4):307–9.
    1. Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda. BMJ Open. 2014 Nov 11;4(11):e005889.
    1. Croce F, Fedeli P, Dahoma M, Deho L, Ramsan M, Adorni F, et al. Risk factors for HIV/AIDS in a low HIV prevalence site of sub-Saharan Africa. Trop Med Int Health. 2007 Sep;12(9):1011–7.
    1. Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C and E in Southern Tanzania. J Med Virol. 1999 Jul;58(3):215–20.
    1. Rashid S, Kilewo C, Aboud S. Seroprevalence of hepatitis B virus infection among antenatal clinic attendees at a tertiary hospital in Dar es Salaam, Tanzania. Tanzan J Health Res. 2014 Jan;16(1):9–15.
    1. Mavenyengwa RT, Moyo SR, Nordbo SA. Streptococcus agalactiae colonization and correlation with HIV-1 and HBV seroprevalence in pregnant women from Zimbabwe. European Journal of Obstretrics & Gynecology and Reproductive Biology. 2009;150:34–8.
    1. Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med. 1999 Aug;45(8):195–8.
    1. Miyahara R, Jasseh M, Gomez P, Shimakawa Y, Greenwood B, Keita K, et al. Barriers to timely administration of birth dose vaccines in The Gambia, West Africa. Vaccine. 2016 Jun 17;34(29):3335–41.
    1. Wiesen E, Diorditsa S, Li X. Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014. Vaccine. 2016 May 27;34(25):2855–62.
    1. World Health Organization . Preventing perinatal Hepatitis B Virus Transmission: A guide for Introducing and Strengthening Hepatitis B birth dose vaccination. 2015. (14 December 2016)
    1. UNICEF . HepB-UNICEF. 2016. (updated 4/14/2016; cited 2016 12/15/2016)
    1. World Health Organization . Summary of the October 2016 meeting of the Strategic Advisory Group of Experts on immunization (SAGE) 2016. (cited 2016 12/14/2016)
    1. Borresen ML, Koch A, Biggar RJ, Ladefoged K, Melbye M, Wohlfahrt J, et al. Effectiveness of the targeted hepatitis B vaccination program in Greenland. Am J Public Health. 2012 Feb;102(2):277–84.
    1. Hutin Y, Hennessey K, Cairns L, Zhang Y, Li H, Zhao L, et al. Improving hepatitis B vaccine timely birth dose coverage: lessons from five demonstration projects in China, 2005-2009. Vaccine. 2013 Dec 27;31(Suppl 9):J49–55.
    1. Hennessey K, Mendoza-Aldana J, Bayutas B, Lorenzo-Mariano KM, Diorditsa S. Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status. Vaccine. 2013 Dec 27;31(Suppl 9):J85–92..
    1. Xeuatvongsa A, Datta SS, Moturi E, Wannemuehler K, Philakong P, Vongxay V, et al. Improving hepatitis B birth dose in rural Lao People's Democratic Republic through the use of mobile phones to facilitate communication. Vaccine. 2016 Nov 11;34(47):5777–84.
    1. Sutanto A, Suarnawa IM, Nelson CM, Stewart T, Soewarso TI. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull World Health Organ. 1999;77(2):119–26.
    1. World Health Organization . Evidence presented to SAGE. 2016. Oct, A systematic review of monovalent hepatitis B vaccine thermostability. (cited 2016 11/14/2016)
    1. Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, et al. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine. 2007 Aug 10;25(32):5985–93.
    1. Wang L, Li J, Chen H, Li F, Armstrong GL, Nelson C, et al. Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Organ. 2007 Sep;85(9):688–94.
    1. Kolwaite AR, Xeuatvongsa A, Ramirez-Gonzalez A, Wannemuehler K, Vongxay V, Vilayvone V, et al. Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR. Vaccine. 2016 Jun 14;34(28):3324–30.
    1. Huong VM, Hipgrave D, Hills S, Nelson C, Hien DS, Cuong NV. Out-of-Cold-Chain Delivery of the Hepatitis B Birth Dose in Four Districts of Vietnam. PATH (Program for Appropriate Technology in Health), 2006. 2006 Oct; Report No.
    1. World Health Organization . Regional Office for Africa, editor. 2016. Prevention, Care and Treatment of Viral Hepatitis in the African Region: Framework for Action, 2016-2020. (cited 17 february 2017)

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit